SG11202110318YA - Immunoassay reagent and immunoassay method - Google Patents

Immunoassay reagent and immunoassay method

Info

Publication number
SG11202110318YA
SG11202110318YA SG11202110318YA SG11202110318YA SG11202110318YA SG 11202110318Y A SG11202110318Y A SG 11202110318YA SG 11202110318Y A SG11202110318Y A SG 11202110318YA SG 11202110318Y A SG11202110318Y A SG 11202110318YA SG 11202110318Y A SG11202110318Y A SG 11202110318YA
Authority
SG
Singapore
Prior art keywords
immunoassay
reagent
immunoassay method
immunoassay reagent
Prior art date
Application number
SG11202110318YA
Other languages
English (en)
Inventor
Mieko Ota
Yuuya INABA
Hiroki Kobayashi
Mitsuaki Yamamoto
Original Assignee
Sekisui Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Medical Co Ltd filed Critical Sekisui Medical Co Ltd
Publication of SG11202110318YA publication Critical patent/SG11202110318YA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L9/00—Compositions of homopolymers or copolymers of conjugated diene hydrocarbons
    • C08L9/06—Copolymers with styrene
    • C08L9/08—Latex
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11202110318YA 2019-03-29 2020-03-27 Immunoassay reagent and immunoassay method SG11202110318YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019067785 2019-03-29
PCT/JP2020/013989 WO2020203755A1 (fr) 2019-03-29 2020-03-27 Réactif de dosage immunologique et procédé de dosage immunologique

Publications (1)

Publication Number Publication Date
SG11202110318YA true SG11202110318YA (en) 2021-10-28

Family

ID=72668475

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202110318YA SG11202110318YA (en) 2019-03-29 2020-03-27 Immunoassay reagent and immunoassay method

Country Status (8)

Country Link
US (1) US20220187323A1 (fr)
EP (1) EP3951389A4 (fr)
JP (1) JPWO2020203755A1 (fr)
KR (1) KR20210146915A (fr)
CN (1) CN113677993A (fr)
SG (1) SG11202110318YA (fr)
TW (1) TW202102850A (fr)
WO (1) WO2020203755A1 (fr)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210723A (en) * 1976-07-23 1980-07-01 The Dow Chemical Company Method of coupling a protein to an epoxylated latex
JPS55110118A (en) * 1979-02-20 1980-08-25 Dow Chemical Co Method of combining epoxylated latex with protein and product formed therefrom
FR2450263A1 (fr) * 1979-02-28 1980-09-26 Dow Chemical Co Procede pour coupler une proteine sur un latex portant des groupes epoxyde et produits obtenus par ce procede
JPS61247966A (ja) * 1985-04-25 1986-11-05 Daikin Ind Ltd 抗原−抗体反応測定用試薬
JP2590330B2 (ja) * 1987-02-17 1997-03-12 三菱化学株式会社 抗原抗体反応の測定法
JP2677753B2 (ja) * 1993-07-22 1997-11-17 株式会社エスアールエル 凝集イムノアッセイ法
JPH0933528A (ja) * 1995-07-18 1997-02-07 Nissui Pharm Co Ltd 免疫分析用反応試薬及びその製造方法
FR2781486B1 (fr) * 1998-07-10 2000-09-08 Atochem Elf Sa Polymerisation en emulsion en presence d'un radical libre stable
JP2001074742A (ja) * 1999-09-06 2001-03-23 Jsr Corp ラテックス免疫比濁法および測定キット
JP2001153869A (ja) * 1999-11-29 2001-06-08 Nippon Paint Co Ltd 診断試薬用ラテックス、その製造方法、および診断試薬
US7432372B2 (en) * 2003-10-31 2008-10-07 Invitrogen Corporation Fluorinated resorufin compounds and their application
AU2006242303A1 (en) * 2005-05-02 2006-11-09 Anp Technologies, Inc. Polymer conjugate enhanced bioassays
JP2007003411A (ja) * 2005-06-24 2007-01-11 Sekisui Chem Co Ltd ヘモグロビンＡ１ｃの測定方法及びヘモグロビンＡ１ｃ測定用キット
EP2049902A4 (fr) * 2006-07-28 2010-09-01 Biosite Inc Dispositifs et procédés pour effectuer des tests de liaison à des récepteurs en utilisant des particules magnétiques
JP2011520108A (ja) * 2008-04-30 2011-07-14 ノバルティス アーゲー 病原性配座異性体についてのアッセイ
KR101824256B1 (ko) * 2009-06-30 2018-01-31 세키스이 메디칼 가부시키가이샤 Ｋｌ-6 측정용 면역 측정 시약
JP6004516B2 (ja) * 2012-03-22 2016-10-12 積水メディカル株式会社 ヘモグロビン類分離用カラム充填剤及びその製造方法
JP6216298B2 (ja) 2014-08-29 2017-10-18 株式会社日立ハイテクノロジーズ 自動分析装置及びそれを用いた分析方法
US20180088118A1 (en) * 2015-02-25 2018-03-29 Sekisui Medical Co., Ltd. Immunological measurement method for l-fabp and measurement reagent used in said method
US10414879B2 (en) * 2015-04-07 2019-09-17 Sabic Global Technologies B.V. Process to produce fluoropolymer-based latex with mechanical stability
JP6731311B2 (ja) 2016-08-09 2020-07-29 株式会社日立ハイテク 自動分析装置
CN107213928B (zh) * 2017-05-31 2019-06-11 深圳市海拓华擎生物科技有限公司 一种微流控芯片及其制备方法

Also Published As

Publication number Publication date
EP3951389A4 (fr) 2022-12-14
KR20210146915A (ko) 2021-12-06
CN113677993A (zh) 2021-11-19
TW202102850A (zh) 2021-01-16
US20220187323A1 (en) 2022-06-16
WO2020203755A1 (fr) 2020-10-08
EP3951389A1 (fr) 2022-02-09
JPWO2020203755A1 (fr) 2020-10-08

Similar Documents

Publication Publication Date Title
ZA202208807B (en) Anti-tigit antibodies and usage method
EP3361252A4 (fr) Méthode de dosage de pivka-ii et procédé de fabrication du réactif ou kit d'immunoessai de pivka-ii
SG11202112112UA (en) Anti-galectin-9 antibodies and uses thereof
IL289656A (en) Anti-tigit antibodies and their application
IL291027A (en) Anti-steap1 antibodies and uses thereof
HK1244537A1 (zh) 凝血酶-抗凝血酶複合體的測定試劑及測定方法
EP3264083A4 (fr) Procédé de dosage immunologique de l-fabp et réactif de dosage utilisé dans ledit procédé
IL291550A (en) Anti-il-27 antibodies and their uses
IL291546A (en) Antibodies against kir3dl3 and their uses
EP3767294A4 (fr) Kit de réactifs, kit de mesure et procédé de mesure
EP3264085A4 (fr) Procédé de dosage immunologique et réactif de dosage utilisé dans le procédé
EP3733782A4 (fr) Particules de complexe métallique et réactif de dosage immunologique utilisant ces dernières
IL291280A (en) Antibodies against cd371 and their uses
EP4075132A4 (fr) Méthode et dispositif d'immunoessai
IL286803A (en) Anti-tauc3 antibodies and uses thereof
SG11202110318YA (en) Immunoassay reagent and immunoassay method
EP3264084A4 (fr) Procédé de dosage immunologique et réactif de dosage utilisé dans ledit procédé
EP3929582A4 (fr) Dispositif et procédé de dosage immunologique
EP4081354C0 (fr) Dispositif et procédé de tri
EP3919887A4 (fr) Procédé de dilution d'échantillon et procédé de dosage immunologique
SG11202102265UA (en) Hemoglobin assay reagent, assay kit and assay method
EP3767293A4 (fr) Kit de réactifs, kit de mesure et procédé de mesure
GB201902630D0 (en) Analyte detection method
GB201902590D0 (en) Antibodies and uses thereof
GB2619178B (en) Analysis device and analysis method